There is still no cure for inflammatory bowel disease. This review covers newer treatments that reflect our understanding of the complex pathogenesis of IBD, with a focus on clinical and endoscopic remission and more precise molecular targeting of inflammatory cascades.
No takes yet. Share an insight, caveat, or question.
Baumgart et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: